Table 3.
Study | Region | Tumor type | Sample size | Test method | Cut off | Outcome measure | HR estimation | Follow up Months |
---|---|---|---|---|---|---|---|---|
Ge 2013 | China | CRC | 189 | qRT-PCR | ROC | OS | Directly | ~90 |
Yan 2015 | China | HCC | 117 | qRT-PCR | Median value | OS | Directly | ~60 |
Shi 2015 | China | ESCC | 194 | qRT-PCR | Median value | OS | Directly | ~60 |
Qin 2016 | China | ESCC | 321 | PCR, Sequencing | Median value | OS | Directly | ~60 |
Cui 2017 | China | GC | 175 | qRT-PCR | Median value | OS | Directly | ~60 |
CRC, Colorectal cancer; HCC, Hepatocellular carcinoma; ESCC, Esophageal squamous cell carcinoma; GC, Gastric cancer; OS, overall survival; ROC, Receiver Operating Characteristic